Among patients diagnosed with osteoporosis, bisphosphonates (BP, 45.4%) were the most frequently prescribed osteoporosis medication before the registration, followed by vitamin D (alfacalcidol, 25.9%; eldecalcitrol, 14.3%), and selective estrogen receptor modulators (SERM, 15.5%). This evidence concerns the gene ESR1 and osteoporosis.